Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (811-820 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Driving distances and loss to follow-up after hematopoietic cell transplantationRahul Banerjee, Alison W Loren
Ejhaem|July 18, 2022
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Ulrich Budde, et al.
Ejhaem|July 18, 2022
Whole body-diffusion weighted imaging for the assessment of treatment response in hairy cell leukaemia: A positive first stepAshwin Algudkar, Dima El-Sharkawi, Matthew Cross, et al.
Ejhaem|July 18, 2022
The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemiaPreeya Bhavsar-Bhakta, Mugahed Hamza, Sepideh Mehravaran, et al.
Ejhaem|July 18, 2022
Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapySasanka Handunnetti, Mary Ann Anderson, Andrew W Roberts, et al.
Ejhaem|July 18, 2022
Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
Ejhaem|July 18, 2022
Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort studyLia C Scott, Juan Li, Lorraine A Cafuir, et al.
Ejhaem|July 18, 2022
Resource utilization and treatment costs of patients with severe hemophilia A: Real-world data from the ATHNdatasetMichael Recht, Chunla He, Er Chen, et al.
Ejhaem|July 18, 2022
Primary central nervous system lymphoma: Inter-compartmental progressionVishal Raval, Elaine Binkley, Mary E Aronow, et al.
Pageof 93

Showing results (811-820 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Driving distances and loss to follow-up after hematopoietic cell transplantationRahul Banerjee, Alison W Loren
Ejhaem|July 18, 2022
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Ulrich Budde, et al.
Ejhaem|July 18, 2022
Whole body-diffusion weighted imaging for the assessment of treatment response in hairy cell leukaemia: A positive first stepAshwin Algudkar, Dima El-Sharkawi, Matthew Cross, et al.
Ejhaem|July 18, 2022
The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemiaPreeya Bhavsar-Bhakta, Mugahed Hamza, Sepideh Mehravaran, et al.
Ejhaem|July 18, 2022
Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapySasanka Handunnetti, Mary Ann Anderson, Andrew W Roberts, et al.
Ejhaem|July 18, 2022
Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphomaTakafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
Ejhaem|July 18, 2022
Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort studyLia C Scott, Juan Li, Lorraine A Cafuir, et al.
Ejhaem|July 18, 2022
Resource utilization and treatment costs of patients with severe hemophilia A: Real-world data from the ATHNdatasetMichael Recht, Chunla He, Er Chen, et al.
Ejhaem|July 18, 2022
Primary central nervous system lymphoma: Inter-compartmental progressionVishal Raval, Elaine Binkley, Mary E Aronow, et al.
Pageof 93